Author

J. Debus

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Abdollahi· 3 shared M. Moustafa· 2 shared A. Mairani· 1 shared A. Runz· 1 shared C. Reid· 1 shared D. Krunic· 1 shared D. Walsh· 1 shared E. Dickes· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

A. Abdollahi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control

I. Dokic, M. Moustafa, T. Tessonnier, S. Meister, F. Ciamarone, M. Akbarpour, D. Krunic, T. Haberer, J. Debus, A. Mairani, A. Abdollahi

This study compares ultra-high-dose rate helium ion radiotherapy (FLASH) with standard dose rate (SDR) in mice, showing FLASH reduces brain injury and neuroinflammation while maintaining tumor control.

bioRxiv · Jun 13, 2024 · PreprintCell Biology

Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model

L. Hartmann, W. Osen, O. L. Eichmüller, T. Kordass, J. Furkel, E. Dickes, C. Reid, J. Debus, S. Brons, A. Abdollahi, M. Moustafa, S. Rieken, S. B. Eichmüller

This study shows that carbon ion radiotherapy combined with CTLA4 blockade induces complete tumor rejection and systemic immune memory in a murine tumor model.

bioRxiv · Jul 22, 2022Immunology

The biomedical sensor Cell-Fit-HD4D, reveals individual tumor cell fate in response to microscopic ion deposition.

M. Niklas, J. Schlegel, H. Liew, D. Walsh, F. Zimmermann, O. Dzyubachyk, T. Holland-Letz, S. Rahmanian, S. Greilich, A. Runz, J. Debus, A. Abdollahi

The paper introduces a biomedical sensor, Cell-Fit-HD4D, to monitor individual tumor cell fate after ion beam therapy and demonstrates its ability to visualize ion beams and track cell responses.

bioRxiv · Mar 12, 2020 · PreprintCancer Biology